awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38776511-12537A2A-3C9D-43A6-B9BF-8868238BEE7E
Q38776511-12537A2A-3C9D-43A6-B9BF-8868238BEE7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38776511-12537A2A-3C9D-43A6-B9BF-8868238BEE7E
S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.
P2860
Q38776511-12537A2A-3C9D-43A6-B9BF-8868238BEE7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38776511-12537A2A-3C9D-43A6-B9BF-8868238BEE7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3043ea15cb952a61bb12aaca3dea757dc605834e
P2860
Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study.